OTCPK:CAKF.F

Stock Analysis Report

Executive Summary

McKesson Europe AG provides logistics and services to the pharmaceutical and healthcare sectors worldwide.

Snowflake

Fundamentals

Moderate growth potential with mediocre balance sheet.

Risks

  • McKesson Europe's last earnings update was 250 days ago.
  • McKesson Europe is not covered by any analysts.

Similar Companies

Share Price & News

How has McKesson Europe's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

CAKF.F

-0.3%

US Healthcare

-0.6%

US Market


1 Year Return

n/a

CAKF.F

-9.2%

US Healthcare

0.7%

US Market

No trading data on CAKF.F.

No trading data on CAKF.F.


Share holder returns

CAKF.FIndustryMarket
7 Day0%-0.3%-0.6%
30 Day0%2.1%4.9%
90 Day0%-0.8%1.7%
1 Yearn/a-7.8%-9.2%3.0%0.7%
3 Yearn/a29.7%24.4%44.8%35.4%
5 Year-13.3%-13.3%66.1%56.2%62.0%44.3%

Price Volatility Vs. Market

How volatile is McKesson Europe's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is McKesson Europe undervalued based on future cash flows and its price relative to the stock market?

2.81x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

McKesson Europe's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

McKesson Europe's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

McKesson Europe is loss making, we can't compare its value to the US Healthcare industry average.

McKesson Europe is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for McKesson Europe, we can't assess if its growth is good value.


Price Based on Value of Assets

McKesson Europe is overvalued based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is McKesson Europe expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

42.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Unable to determine if McKesson Europe is high growth as no revenue estimate data is available.

McKesson Europe's earnings are expected to grow significantly at over 20% yearly.

Unable to compare McKesson Europe's revenue growth to the United States of America market average as no estimate data is available.

McKesson Europe's earnings growth is expected to exceed the United States of America market average.

McKesson Europe's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if McKesson Europe will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has McKesson Europe performed over the past 5 years?

-27.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

McKesson Europe does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare McKesson Europe's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare McKesson Europe's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if McKesson Europe has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if McKesson Europe has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if McKesson Europe improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is McKesson Europe's financial position?


Financial Position Analysis

McKesson Europe is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

McKesson Europe's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

McKesson Europe's level of debt (71.2%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (90.8% vs 71.2% today).

Debt is not well covered by operating cash flow (19.5%, less than 20% of total debt).

McKesson Europe is making a loss, therefore interest payments are not well covered by earnings.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 3.8x debt.


Next Steps

Dividend

What is McKesson Europe's current dividend yield, its reliability and sustainability?

3.17%

Current Dividend Yield


Dividend Yield and Payments Analysis

McKesson Europe's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.45%).

McKesson Europe's dividend is below the markets top 25% of dividend payers in United States of America (3.67%).

Whilst dividend payments have been stable, McKesson Europe has been paying a dividend for less than 10 years.

McKesson Europe has only been paying a dividend for 2 years, and since then there has been no growth.


Current Payout to Shareholders

The company is paying a dividend however it is incurring a loss.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of McKesson Europe's salary, the management and board of directors tenure and is there insider trading?

4.5yrs

Average management tenure


CEO

Kevin Kettler 0

0.3yrs

Tenure

0

Mr. Kevin Kettler has been Chairman of the Management Board at McKesson Europe AG since November 1, 2018 and its Labour Relations Director since November 2018. 


Management Age and Tenure

4.5yrs

Average Tenure

55yo

Average Age

The tenure for the McKesson Europe management team is about average.


Board Age and Tenure

4.3yrs

Average Tenure

58yo

Average Age

The tenure for the McKesson Europe board of directors is about average.


Insider Trading

No 3 month insider trading information.


Ownership Breakdown


Management Team

  • Nicole Herold

    Head of Corporate Investor Relations

    • Tenure: 0yrs
  • Alain Vachon (55yo)

    CFO & Member of the Management Board

    • Tenure: 4.7yrs
    • Compensation: €219.00k
  • Holger Landauer (32yo)

    Head of Controlling

    • Tenure: 0yrs
  • Tilo Köster (57yo)

    Labour Relations Director

    • Tenure: 4.5yrs
    • Compensation: €277.00k
  • Kevin Kettler

    Chairman of the Management Board & Labour Relations Director

    • Tenure: 0.3yrs

Board Members

  • W. M. Rehder (65yo)

    Deputy Chairman of the Supervisory Board

    • Tenure: 0yrs
    • Compensation: €20.30k
  • Ihno Goldenstein (45yo)

    Deputy Chairman of the Supervisory Board

    • Tenure: 0yrs
    • Compensation: €26.40k
  • Jörg Lauenroth-Mago (62yo)

    Member of the Supervisory Board

    • Tenure: 9.8yrs
    • Compensation: €16.80k
  • Ulrich Neumeister (61yo)

    Employee representative Member of the Supervisory Board

    • Tenure: 15.9yrs
    • Compensation: €18.80k
  • Lori Schechter (56yo)

    Member of the Supervisory Board

    • Tenure: 2.7yrs
  • Brian Tyler (51yo)

    Chairman of Supervisory Board

    • Tenure: 1.2yrs
  • Susan Naumann (58yo)

    Employee representative Member of the Supervisory Board

    • Tenure: 10.9yrs
    • Compensation: €16.80k
  • Kathy McElligott (62yo)

    Member of the Supervisory Board

    • Tenure: 1.3yrs
  • Pauline Lindwall (57yo)

    Member of the Supervisory Board

    • Tenure: 5.8yrs
    • Compensation: €16.80k
  • Detlef Bernhardt

    Employee representative Member of the Supervisory Board

    • Tenure: 1.6yrs

Company Information

McKesson Europe AG's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: McKesson Europe AG
  • Ticker: CAKF.F
  • Exchange: OTCPK
  • Founded: 1835
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: €5.324b
  • Listing Market Cap: €5.986b
  • Shares outstanding: 203.22m
  • Website: https://www.mckesson.eu/mck-en

Number of Employees


Location

  • McKesson Europe AG
  • Stockholmer Platz 1
  • Stuttgart
  • 70137
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CAKF.YOTCPK (Pink Sheets LLC)UNSPONSORED ADRUSUSDNo data
CAKF.FOTCPK (Pink Sheets LLC)YesRegistered SharesUSUSDJan 1992
0OPBLSE (London Stock Exchange)YesRegistered SharesGBEURJan 1992
CLS1HMSE (Hamburg Stock Exchange)YesRegistered SharesDEEURJan 1992
CAKF.YOTCPK (Pink Sheets LLC)UNSPONSORED ADRUSUSDOct 2008

Biography

McKesson Europe AG provides logistics and services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Consumer Solutions and Pharmacy Solutions. The Consume ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/03/10 00:09
End of Day Share Price2018/12/10 00:00
Earnings2018/03/31
Annual Earnings2018/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.